10-Q: CN Healthy Food Tech Faces Nasdaq Delisting Amid Financial Woes

CN Healthy Food Tech Group Corp. reports revenue growth but faces severe financial challenges including defaults on promissory notes and a Nasdaq delisting determination, impacting its operational future.

Summary

• CN Healthy Food Tech Group Corp. reported revenue of $8.73 million for Q2 2026, a 17.1% increase year-over-year, and $14.56 million for the first six months of 2026, up 21.6% from the prior year.
• Despite revenue growth, the company experienced a net loss of $2.75 million for the first six months of 2026, a significant decrease from a net income of $3.70 million in the same period of 2025.
• The company is facing significant financial distress, with defaults on three promissory notes totaling approximately $3.5 million in principal and $335,908 in accrued default interest.
• Trading of the company's common stock and warrants on the Nasdaq Capital Market has been halted since October 1, 2025, and on July 16, 2026, Nasdaq issued a determination to delist the securities.
• The company's disclosure controls and procedures were found to be not effective due to insufficient in-house U.S. GAAP/SEC reporting expertise and other control deficiencies.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to significant financial distress, ongoing defaults on promissory notes, and the impending delisting from Nasdaq, despite revenue growth.

Positives

• Revenue increased by 17.1% to $8.73 million for the three months ended June 30, 2026, compared to $7.46 million in the same period of 2025.
• Revenue increased by 21.6% to $14.56 million for the six months ended June 30, 2026, compared to $11.98 million in the same period of 2025.
• Gross profit increased by 26.3% to $6.24 million for the three months ended June 30, 2026, and by 51.6% to $10.61 million for the six months ended June 30, 2026.
• The company's own production base, operational since October 2025, has lowered per-unit production costs.
• Cash and cash equivalents stood at $23.3 million as of June 30, 2026, which management believes is sufficient for PRC operating subsidiaries' needs for at least the next twelve months.

Negatives

• Net income for the six months ended June 30, 2026, was $2.75 million, a 25.6% decrease from $3.70 million in the same period of 2025.
• Total operating expenses for the six months ended June 30, 2026, increased by 105.5% to $4.76 million, largely due to $2.045 million in amortization of shares issued for services.
• Other income (expense), net, swung from a net income of $247,845 for the six months ended June 30, 2025, to a net expense of $738,116 for the same period in 2026, primarily due to a $436,961 CSRC administrative penalty and $335,908 in default interest.
• The effective tax rate for the six months ended June 30, 2026, was 46.1%, significantly higher than the 25.0% in the prior year, due to non-deductible expenses and a full valuation allowance against U.S. deferred tax assets.
• Net cash used in operating activities for the six months ended June 30, 2026, was $10.63 million, a substantial increase from $1.47 million used in the same period of 2025, driven by a decrease in customer advances and increased inventory procurement.

Risks

• The company received a determination letter from Nasdaq on July 16, 2026, to delist its common stock and warrants from the Nasdaq Capital Market, with an appeal pending.
• Trading of the company's securities has been halted on Nasdaq since October 1, 2025.
• Three promissory notes issued in connection with the Business Combination are in default, with aggregate outstanding principal of approximately $3.5 million and accrued default interest of $335,908.
• The company is in default of its payment obligations under the September 2025 Note Payable, the Assumed Note Payable, and the Sponsor Note Payable.
• The CSRC imposed fines totaling RMB 4,500,000 (approximately $660,000) on a subsidiary and its CEO for failing to complete mandatory offshore listing filing procedures.
• The issuance of common stock to satisfy defaulted note obligations could result in substantial dilution to existing stockholders.
• The company's disclosure controls and procedures were not effective due to insufficient in-house U.S. GAAP/SEC reporting expertise, segregation of duties, lack of supervision, and limited documentation.

Future Outlook

The company believes its existing cash and cash equivalents are sufficient to meet working capital and capital expenditure needs for its PRC operating subsidiaries for at least the next twelve months. However, the company may require additional capital resources in the future, the availability of which on acceptable terms cannot be assured.

Management Comments

• Management evaluated the going concern conditions and concluded that substantial doubt has been alleviated due to cash on hand, sequential growth, active negotiations with noteholders, and a planned intra-group financing arrangement.
• Management believes the outcome of legal matters will not have a significant adverse effect on the company's financial position, results of operations, or cash flows.
• Management concluded that the company's disclosure controls and procedures were not effective at a reasonable assurance level due to insufficient in-house U.S. GAAP/SEC reporting expertise, segregation of duties, lack of supervision and review, and limited documentation.

Industry Context

StockSavvy.ai notes that CN Healthy Food Tech Group Corp. operates in the health food sector, leveraging AI and biotechnology. While the company shows revenue growth, the significant financial distress and regulatory issues (Nasdaq delisting, CSRC penalties) overshadow the operational performance, indicating a high-risk environment for companies in this sector facing compliance and financial hurdles.

Comparison to Industry Standards

• The company's revenue growth of 17.1% (Q2) and 21.6% (YTD) in the health food sector is positive, but this is contrasted by a significant increase in operating expenses (105.5% YTD) and a decline in net income (25.6% YTD).
• The company's effective tax rate of 46.1% for the first six months of 2026 is substantially higher than the PRC statutory rate of 25%, indicating significant non-deductible expenses or other tax complexities not typical for healthy, growing companies.
• The company's reliance on internal production since October 2025, leading to lower per-unit costs, is a positive operational step, but it is overshadowed by the financial and regulatory risks.
• The company's cash position of $23.3 million is substantial, but its availability to meet U.S. holding company obligations is constrained by PRC foreign exchange controls, a common challenge for companies with significant PRC operations.

Corporate Governance

Legal Proceedings

• The company received a determination letter from Nasdaq on July 16, 2026, to delist its common stock and warrants, with an appeal pending.
• Trading of the company's securities has been halted on Nasdaq since October 1, 2025.
• The company is in default on three promissory notes, with aggregate outstanding principal of approximately $3.5 million and accrued default interest of $335,908.
• A CSRC administrative penalty of RMB 3,000,000 was imposed on a subsidiary and RMB 1,500,000 on the CEO for failing to complete mandatory offshore listing filing procedures; these fines have been paid.

Related Party Transactions

• The company has outstanding principal of $454,690 on notes payable to its Sponsor, Bengochea SPAC Sponsors I LLC (Sponsor Note Payable and Assumed Sponsor Note Payable), as of June 30, 2026, with accrued default interest of approximately $42,417.
• The company is in discussions with the Sponsor to extend the maturity date of these notes.

Stakeholder Impact

• Shareholders face significant risk due to the Nasdaq delisting determination, potential dilution from note conversions, and the overall financial instability.
• Lenders and creditors are impacted by the defaults on promissory notes and the ongoing discussions for extensions.
• Suppliers may face payment uncertainties given the company's financial distress.
• Employees may experience uncertainty regarding the company's future operations and stability.

Next Steps

• The company is in discussions with noteholders to extend maturity dates and address defaults on promissory notes.
• The company has requested an appeal of Nasdaq's determination to delist its securities.
• Management is pursuing an intra-group financing arrangement to potentially alleviate liquidity concerns.
• The company is continuing its business operations through its wholesale distribution and live-stream sales segments.

Key Dates

Recommendation

The company is facing severe financial distress, including defaults on significant promissory notes and a determination by Nasdaq to delist its securities. Despite revenue growth, the substantial increase in operating expenses, significant net income decline, and ongoing regulatory issues create an extremely high-risk investment profile. The potential for further dilution from note conversions exacerbates these concerns, making it a sell recommendation.

Keywords

health food, biotechnology, AI technology, wholesale distribution, live-stream sales, Nasdaq delisting, promissory note default, CSRC penalty